Cerus Corp. | Income Statement

Fiscal year is January-December. All values USD Thousands.
2013
2014
2015
2016
2017
2018
Sales/Revenue
39,657.00
36,416.00
34,223.00
39,275.00
51,326.00
76,051
Cost of Goods Sold (COGS) incl. D&A
22,804.00
21,390.00
23,666.00
20,497.00
22,633.00
31,334
Gross Income
16,853.00
15,026.00
10,557.00
18,778.00
28,693.00
44,717
SG&A Expense
45,152.00
59,529.00
71,632.00
80,075.00
86,123.00
99,405
EBIT
28,299.00
44,503.00
-
61,297.00
57,530.00
54,988
Unusual Expense
15,099.00
7,708.00
3,566.00
150.00
-
-
Non Operating Income/Expense
799.00
1,166.00
325.00
1,161.00
3,854.00
1,661
Interest Expense
520.00
599.00
1,705.00
2,445.00
3,022.00
4,008
Pretax Income
43,119.00
38,560.00
59,539.00
62,731.00
56,698.00
57,335
Income Tax
218.00
195.00
3,671.00
175.00
3,887.00
229
Consolidated Net Income
43,337.00
38,755.00
55,868.00
62,906.00
60,585.00
57,564
Net Income
43,337.00
38,755.00
55,868.00
62,906.00
60,585.00
57,564
Net Income After Extraordinaries
43,337.00
38,755.00
55,868.00
62,906.00
60,585.00
57,564
Net Income Available to Common
43,337.00
38,755.00
55,868.00
62,906.00
60,585.00
57,564
EPS (Basic)
0.64
0.61
0.61
0.62
0.56
0.44
Basic Shares Outstanding
67,569.00
74,767.00
96,068.00
101,826.00
108,221.00
131,663
EPS (Diluted)
0.64
0.61
0.61
0.62
0.56
0.44
Diluted Shares Outstanding
67,569.00
76,534.00
96,905.00
101,826.00
108,221.00
131,663
EBITDA
27,742.00
43,088.00
59,376.00
59,480.00
55,719.00
53,543
Other Operating Expense
-
-
-
-
100.00
300

About Cerus

View Profile
Address
2550 Stanwell Drive
Concord California 94520
United States
Employees -
Website http://www.cerus.com
Updated 07/08/2019
Cerus Corp. engages in the research, development, and manufacture of biomedical and surgical products. It produces blood system for platelets and plasma. It markets its products under the INTERCEPT brand.